Profile: Oncomethylome Sciences Bv develops molecular diagnostic tests to assist physician in making more informed diagnoses and treatment decisions. We provide two types of tests that are molecular cancer diagnostics and personalized treatment solutions. We develop novel molecular cancer diagnostic tests to help physicians detect cancer accurately in early stages of cancer development and our diagnostic program begins with identification of genes methylated in specific cancers using tumor-derived and normal cell lines. Our oncomethylome sciences personalized treatment solutions are designed to help doctors most effectively treat their cancer patients. We provide two types of products for treatment. Our pharmacogenomics tests predict, which drug is likely to be most effective for a specific patient by analyzing molecular make-up of an individual patient's tumor and recurrence prediction test distinguishes between aggressive and non-aggressive tumors again based on molecular make-up of the tumor that predict likelihood of disease recurrence after therapy.